Edition:
India

People: Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

6.16USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$6.16
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,884
52-wk High
$8.14
52-wk Low
$2.81

Rowlinson, Scott 

Dr. Scott W. Rowlinson, Ph.D. is Vice President - Research of the Company. From May 2000 to February 2014, Dr. Rowlinson worked as a research scientist at Eli Lilly & Company, a pharmaceutical company. Dr. Rowlinson holds a B.S. in Physiology & Pharmacology and a Ph.D. in Physiology and Pharmacology from the University of Queensland, Australia.

Basic Compensation

Total Annual Compensation, USD 418,127
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 14,851
Fiscal Year Total, USD 432,978

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --